Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure
Open accessThe DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Despite intense research, it remains intriguing why hormonal therapies in general and progestins in particular sometimes fail in endometriosis. OBJECTIVE AND RATIONALE: We review here the action mechanisms of progesterone receptor ligands in endometriosis, identify critical differences between the effects of progestins on normal endometrium and endometriosis and envisage pathways to escape drug resistance and improve the therapeutic response of endometriotic lesions to such treatments. SEARCH METHODS: We performed a systematic Pubmed search covering articles published since 1958 about the use of progestins, estro-progestins and selective progesterone receptor modulators, to treat endometriosis and its related symptoms. Two reviewers screened the titles and abstracts to select articles for full-text assessment. OUTCOMES: Progesterone receptor signalling leads to down-regulation of estrogen receptors and restrains local estradiol production through interference with aromatase and 17 beta-hydroxysteroid dehydrogenase type 1. Progestins inhibit cell proliferation, inflammation, neovascularisation and neurogenesis in endometriosis. However, progesterone receptor expression is reduced and disrupted in endometriotic lesions, with predominance of the less active isoform (PRA) over the full-length, active isoform (PRB), due to epigenetic abnormalities affecting the PGR gene transcription. Oxidative stress is another mechanism involved in progesterone resistance in endometriosis. Among the molecular targets of progesterone in the normal endometrium that resist progestin action in endometriotic cells are the nuclear transcription factor FOXO1, matrix metalloproteinases, the transmembrane gap junction protein connexin 43 and paracrine regulators of estradiol metabolism. Compared to other phenotypes, deep endometriosis appears to be more resistant to size regression upon medical treatments. Individual genetic characteristics can affect the bioavailability and pharmacodynamics of hormonal drugs used to treat endometriosis and, hence, explain part of the variability in the therapeutic response. WIDER IMPLICATIONS: Medical treatment of endometriosis needs urgent innovation, which should start by deeper understanding of the disease core features and diverse phenotypes and idiosyncrasies, while moving from pure hormonal treatments to drug combinations or novel molecules capable of restoring the various homeostatic mechanisms disrupted by endometriotic lesions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, they have antiestrogenic effect causing endometrial pseudodecidualisation, inhibit inflammatory response, provoke apoptosis of endometriotic cells, reduce oxidative stress, inhibit angiogenesis and suppress expression of matrix metalloproteinases [5, 26] (Fig. 4).”
From Hormonal treatments for endometriosis: The endocrine background (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Reis et al. [56] summarized the effect of progestins on endometriotic lesions as generating different levels of downregulation of ERs, a drop in local E2 production, a reduction in inflammation, and creation of a pseudo-pregnancy condition.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [56]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“the risk of venous or arterial thrombosis is not negligible [54,55,56,57,58,59,60,61,62,63,64,65,66,67].”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [56]
Experimental — accuracy not yet measuredIn the citing paper
“A recent review by Reis et al. [56] also confirms that deep endometriosis appears to be more resistant to regression upon medical treatment.”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [56]
In the citing paper
“In the present paper, we thoroughly scrutinized the concept of progesterone resistance as an explanation for why 33% of patients do not respond to OCPs and progestins, with this percentage climbing even higher in women with deep nodular endometriosis [46,47,56,58].”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sampson, J. A. (1927) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30003-x · Cited by 2,334
Nisolle, M., & Donnez, J. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)00191-x · Cited by 1,279
Cyclic Decidualization of the Human Endometrium in Reproductive Health and Failure
Gellersen, B., & Brosens, J. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1045 · Cited by 1,139
(1927) · PubMed Central · Cited by 1,008
Global gene profiling in human endometrium during the window of implantation
Kao, L. C., Tulac, S., Lobo, S., Imani, B., Yang, J. P., Germeyer, A., Osteen, K., Taylor, R. N., Lessey, B. A., & Giudice, L. C. (2002) · Endocrinology · doi:10.1210/endo.143.6.8885 · Cited by 727 · cited 1×
“PGRMC-1 transcript (Kao et al., 2002) and protein (Chen et al.”
BackgroundWorld Endometriosis Society consensus on the classification of endometriosis
Johnson, N. P., Hummelshoj, L., Adamson, G. D., Keckstein, J., Taylor, H. S., Abrao, M. S., Bush, D., Kiesel, L., Tamimi, R., Sharpe-Timms, K. L., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dew293 · Cited by 664
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer
Kim, J. J., Kurita, T., & Bulun, S. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1043 · Cited by 520
Stanczyk, F. Z., Hapgood, J. P., Winer, S., & Mishell, D. R. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1008 · Cited by 429
Role of nuclear progesterone receptor isoforms in uterine pathophysiology
Patel, B., Elguero, S., Thakore, S., Dahoud, W., Bedaiwy, M., & Mesiano, S. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu056 · Cited by 353 · cited 1×
“However, the evidence available thus far suggests that both PR isoforms mediate the anti-inflammatory actions of progesterone in the endometrium (Patel et al., 2015).”
BackgroundSapkota, Y., Steinthorsdottir, V., Morris, A. P., Fassbender, A., Rahmioglu, N., De Vivo, I., Buring, J. E., Zhang, F., Edwards, T. L., Jones, S., et al. (2017) · Nature Communications · doi:10.1038/ncomms15539 · Cited by 344 · cited 1×
“metabolism have been investigated in women with endometriosis (Bozdag et al., 2010; Moreno et al., 2012; Sapkota et al., 2017), but the association of such polymorphisms with the individual response”
BackgroundProgesterone resistance in endometriosis: origins, consequences and interventions
Patel, B. G., Rudnicki, M., Yu, J., Shu, Y., & Taylor, R. N. (2017) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13156 · Cited by 336
Long-term treatment of uterine fibroids with ulipristal acetate☆
Donnez, J., Vázquez, F., Tomaszewski, J., Nouri, K., Bouchard, P., Fauser, B. C. J. M., Barlow, D. H., Palacios, S., Donnez, O., Bestel, E., et al. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.008 · Cited by 332
Promoter Hypermethylation of Progesterone Receptor Isoform B (PR-B) in Endometriosis
Wu, Y., Strawn, E., Basir, Z., Halverson, G., & Guo, S.-W. (2006) · Epigenetics · doi:10.4161/epi.1.2.2766 · Cited by 321
Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis
Brown, J., Crawford, T. J., Allen, C., Hopewell, S., & Prentice, A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004753.pub4 · Cited by 308
Reactive Oxygen Species Controls Endometriosis Progression
Ngô, C., Chéreau, C., Nicco, C., Weill, B., Chapron, C., & Batteux, F. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080804 · Cited by 292
Self-citationRiccio, L. D. G. C., Santulli, P., Marcellin, L., Abrão, M. S., Batteux, F., & Chapron, C. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.010 · Cited by 279
Self-citationMote, P. A., Balleine, R. L., McGowan, E. M., & Clarke, C. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5928 · Cited by 270
Endometriosis and nuclear receptors
Yilmaz, B. D., & Bulun, S. E. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz005 · Cited by 243
Estrogen-progestins and progestins for the management of endometriosis
Vercellini, P., Buggio, L., Berlanda, N., Barbara, G., Somigliana, E., & Bosari, S. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.022 · Cited by 243
Ailawadi, R. K., Jobanputra, S., Kataria, M., Gurates, B., & Bulun, S. E. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.09.029 · Cited by 236
Rich innervation of deep infiltrating endometriosis
Wang, G., Tokushige, N., Markham, R., & Fraser, I. S. (2008) · Human Reproduction · doi:10.1093/humrep/den464 · Cited by 232
Pathogenetic Mechanisms of Deep Infiltrating Endometriosis
Tosti, C., Pinzauti, S., Santulli, P., Chapron, C., & Petraglia, F. (2015) · Reproductive Sciences · doi:10.1177/1933719115592713 · Cited by 222 · cited 2×
“Structurally and functionally, endometriotic lesions are not all the same (Tosti et al., 2015).”
BackgroundSelf-citationClinical Studies with an Antigonadotropin-Danazol
Greenblatt, R. B., Dmowski, W. P., Mahesh, V. B., & Scholer, H. F. L. (1971) · Fertility and Sterility · doi:10.1016/s0015-0282(16)38045-1 · Cited by 219
Anastrazole and oral contraceptives: a novel treatment for endometriosis
Amsterdam, L. L., Gentry, W., Jobanputra, S., Wolf, M., Rubin, S. D., & Bulun, S. E. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.02.018 · Cited by 219
Danazol: Endocrine pharmacology and therapeutic applications
Barbieri, R. L., & Ryan, K. J. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90611-6 · Cited by 208
Casper, R. F. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.01.003 · Cited by 205 · cited 2×
“Casper (2017) provides an empirical framework to explain why combined hormonal contraceptives may be less effective than isolated progestins to alleviate endometriosis symptoms and probably ineffective to inhibit endometriosis progression.”
BackgroundVercellini, P., Pietropaolo, G., De Giorgi, O., Pasin, R., Chiodini, A., & Crosignani, P. G. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.03.083 · Cited by 197 · cited 2×
“To avoid estrogen association RCTs did not show meaningful differences between isolated progestins and progestin-estrogen associations (Cheewadhanaraks et al., 2012; Razzi et al., 2007b; Vercellini et al., 2002; Vercellini et al., 2005).”
BackgroundProgesterone Receptor Isoform A But Not B Is Expressed in Endometriosis1
Attia, G. R., Zeitoun, K., Edwards, D., Johns, A., Carr, B. R., & Bulun, S. E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6739 · Cited by 193
Medical treatment of endometriosis-related pain
Vercellini, P., Buggio, L., Frattaruolo, M. P., Borghi, A., Dridi, D., & Somigliana, E. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.015 · Cited by 188
Bruner-Tran, K. L., Eisenberg, E., Yeaman, G. R., Anderson, T. A., McBean, J., & Osteen, K. G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020418 · Cited by 187
(1998) · bchm · doi:10.1515/bchm.1998.379.7.907 · Cited by 186
Bouchard, P., Chabbert-Buffet, N., & Fauser, B. C. J. M. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.08.021 · Cited by 184
Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
Veth, V. B., van de Kar, M. M., McDonnell, R., Julania, S., & Hart, R. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008475.pub2 · Cited by 182
Vercellini, P., De Giorgi, O., Mosconi, P., Stellato, G., Vicentini, S., & Crosignani, P. G. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02951-x · Cited by 180 · cited 2×
“To avoid estrogen association RCTs did not show meaningful differences between isolated progestins and progestin-estrogen associations (Cheewadhanaraks et al., 2012; Razzi et al., 2007b; Vercellini et al., 2002; Vercellini et al., 2005).”
BackgroundReduction of apoptosis and proliferation in endometriosis
Béliard, A., Noël, A., & Foidart, J.-M. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.11.048 · Cited by 180
Endometriosis: ancient disease, ancient treatments
Nezhat, C., Nezhat, F., & Nezhat, C. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.08.001 · Cited by 175
Yin, X., Pavone, M. E., Lu, Z., Wei, J., & Kim, J. J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1527 · Cited by 168
The use of newer progestins in the treatment of endometriosis
Kistner, R. W. (1958) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(58)90384-3 · Cited by 159
Seracchioli, R., Mabrouk, M., Manuzzi, L., Vicenzi, C., Frasca, C., Elmakky, A., & Venturoli, S. (2009) · Human Reproduction · doi:10.1093/humrep/dep259 · Cited by 158 · cited 2×
“Therapeutic regimen To change therapeutic regimen Systematic review: continuous administration may be better than cyclic regimens (Seracchioli et al., 2009).”
BackgroundEndometriosis: current and future medical therapies
Vercellini, P., Somigliana, E., Viganò, P., Abbiati, A., Daguati, R., & Crosignani, P. G. (2007) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2007.10.001 · Cited by 152
THE DISTRIBUTION OF ADENOMYOMAS CONTAINING UTERINE MUCOSA
CULLEN, T. S. (1920) · Archives of Surgery · doi:10.1001/archsurg.1920.01110020002001 · Cited by 149
Progesterone Resistance in Endometriosis: an Acquired Property?
McKinnon, B., Mueller, M., & Montgomery, G. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.05.006 · Cited by 149
Horie, S., Harada, T., Mitsunari, M., Taniguchi, F., Iwabe, T., & Terakawa, N. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.042 · Cited by 146
The effect of contraceptive steroids on hypothalamic-pituitary function
Mishell, D. R., Kletzky, O. A., Brenner, P. F., Roy, S., & Nicoloff, J. T. (1977) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(77)90295-2 · Cited by 141
Santulli, P., Chouzenoux, S., Fiorese, M., Marcellin, L., Lemarechal, H., Millischer, A.-E., Batteux, F., Borderie, D., & Chapron, C. (2015) · Human Reproduction · doi:10.1093/humrep/deu290 · Cited by 137
Self-citationFerrero, S., Camerini, G., Seracchioli, R., Ragni, N., Venturini, P. L., & Remorgida, V. (2009) · Human Reproduction · doi:10.1093/humrep/dep302 · Cited by 134
Vercellini, P., Somigliana, E., Consonni, D., Frattaruolo, M. P., De Giorgi, O., & Fedele, L. (2012) · Human Reproduction · doi:10.1093/humrep/des313 · Cited by 129
Vercellini, P., Bracco, B., Mosconi, P., Roberto, A., Alberico, D., Dhouha, D., & Somigliana, E. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.11.016 · Cited by 127
Release of LH and FSH after Administration of Synthetic LH-Releasing Hormone*
Kastin, A. J., Schally, A. V., Gual, C. G., & Arimura, A. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-4-753 · Cited by 123
Proteomic Characterization of Midproliferative and Midsecretory Human Endometrium
Chen, J. I.-C., Hannan, N. J., Mak, Y., Nicholls, P. K., Zhang, J., Rainczuk, A., Stanton, P. G., Robertson, D. M., Salamonsen, L. A., & Stephens, A. N. (2009) · Journal of Proteome Research · doi:10.1021/pr801024g · Cited by 121
Machado, D. E., Abrão, M. S., Berardo, P. T., Takiya, C. M., & Nasciutti, L. E. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.05.076 · Cited by 119
Kulak, J., Fischer, C., Komm, B., & Taylor, H. S. (2011) · Endocrinology · doi:10.1210/en.2010-1010 · Cited by 112
Progesterone Receptor Regulation of Uterine Adaptation for Pregnancy
Wu, S., Li, R., & DeMayo, F. J. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.04.001 · Cited by 111
Liu, X., Zhang, Q., & Guo, S.-W. (2018) · Reproductive Sciences · doi:10.1177/1933719117718275 · Cited by 110 · cited 3×
“Deep rectal lesions express PR isoforms both at glands and stroma (Vinci et al., 2016; Zanatta et al., 2015), but, when compared to normal endometrium, PRB immunoreactivity is suppressed in DIE and even more in OMA (Liu et al., 2018) (Table I).”
BackgroundWang, L., Ellsworth, K. A., Moon, I., Pelleymounter, L. L., Eckloff, B. W., Martin, Y. N., Fridley, B. L., Jenkins, G. D., Batzler, A. J., Suman, V. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3224 · Cited by 109
Hayashi, A., Tanabe, A., Kawabe, S., Hayashi, M., Yuguchi, H., Yamashita, Y., Okuda, K., & Ohmichi, M. (2012) · Journal of Ovarian Research · doi:10.1186/1757-2215-5-31 · Cited by 109
Okada, H. (2001) · Molecular Human Reproduction · doi:10.1093/molehr/7.4.341 · Cited by 104 · cited 1×
“logical and functional changes, including the production of prolactin, a typical marker of decidualisation (Okada et al., 2001).”
BackgroundEndometriosis, a modern syndrome.
Brosens, I. A., & Benagiano, G. (2011) · PubMed Central · Cited by 103
Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis
Razzi, S., Luisi, S., Calonaci, F., Altomare, A., Bocchi, C., & Petraglia, F. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.12.077 · Cited by 100
Self-citationLi, Y., Adur, M. K., Kannan, A., Dávila, J., Zhao, Y., Nowak, R. A., Bagchi, M. K., Bagchi, I. C., & Li, Q. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165347 · Cited by 98
Structural and functional analysis of domains of the progesterone receptor
Hill, K. K., Roemer, S. C., Churchill, M. E. A., & Edwards, D. P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.017 · Cited by 96
Carvalho, N., Margatho, D., Cursino, K., Benetti-Pinto, C. L., & Bahamondes, L. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.07.003 · Cited by 96 · cited 1×
“However, an open-label RCT suggested that subdermal etonogestrel implant and LNG-IUS may be equally effective to treat endometriosis-associated pelvic pain and dysmenorrhea (Carvalho et al., 2018).”
BackgroundIs it time for a paradigm shift in drug research and development in endometriosis/adenomyosis?
Guo, S.-W., & Groothuis, P. G. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy020 · Cited by 95
Choi, J., Jo, M., Lee, E., Lee, D., & Choi, D. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.05.020 · Cited by 92
Caruso, S., Iraci, M., Cianci, S., Fava, V., Casella, E., & Cianci, A. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0460-6 · Cited by 92
COUZINET, B., LE, S. N., BRAILLY, S., & SCHAISON, G. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-4-1031 · Cited by 89
Miyashita, M., Koga, K., Takamura, M., Izumi, G., Nagai, M., Harada, M., Hirata, T., Hirota, Y., Fujii, T., & Osuga, Y. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.911279 · Cited by 89
Bilian, X., Zeng, T., Wu, S., Sun, H., & Xiao, N. (1995) · Contraception · doi:10.1016/0010-7824(95)00102-g · Cited by 86
Hyperinnervation in Intestinal Deep Infiltrating Endometriosis
Wang, G., Tokushige, N., Russell, P., Dubinovsky, S., Markham, R., & Fraser, I. S. (2009) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2009.07.012 · Cited by 85
Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats
Katsuki, Y., Takano, Y., Futamura, Y., Shibutani, Y., Aoki, D., Udagawa, Y., & Nozawa, S. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380216 · Cited by 84 · cited 1×
“spleen, decreases the number of peritoneal fluid cells, decreases IL1β production by peritoneal macrophages (Katsuki et al., 1998) and inhibits IL-1β-induced CCL20 release by an endometriotic epithe-”
BackgroundHarada, T., Kosaka, S., Elliesen, J., Yasuda, M., Ito, M., & Momoeda, M. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.07.1165 · Cited by 84
Dinh, A., Sriprasert, I., Williams, A. R. W., & Archer, D. F. (2015) · Contraception · doi:10.1016/j.contraception.2015.01.008 · Cited by 83
Nilsson, C. G., Lähteenmäki, P., & Luukkainen, T. (1980) · Contraception · doi:10.1016/0010-7824(80)90003-7 · Cited by 82
Influence of route of administration on progesterone metabolism
Lignieres, B. D., Dennerstein, L., & Bäckström, T. C. (1995) · Maturitas · doi:10.1016/0378-5122(94)00882-8 · Cited by 81
Bedaiwy, M. A., Dahoud, W., Skomorovska-Prokvolit, Y., Yi, L., LIU, J. H., Falcone, T., Hurd, W. W., & Mesiano, S. A. (2015) · Reproductive Sciences · doi:10.1177/1933719115585145 · Cited by 81
Effect of progestogens and combined oral contraceptives on nerve fibers in peritoneal endometriosis
Tokushige, N., Markham, R., Russell, P., & Fraser, I. S. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.07.1774 · Cited by 80
Leone Roberti Maggiore, U., Remorgida, V., Scala, C., Tafi, E., Venturini, P. L., & Ferrero, S. (2014) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12326 · Cited by 80
González-Foruria, I., Santulli, P., Chouzenoux, S., Carmona, F., Chapron, C., & Batteux, F. (2017) · MHR: Basic science of reproductive medicine · doi:10.1093/molehr/gax028 · Cited by 80
Self-citationShimizu, Y., Mita, S., Takeuchi, T., Notsu, T., Mizuguchi, K., & Kyo, S. (2010) · Steroids · doi:10.1016/j.steroids.2010.08.010 · Cited by 79
Wu, Y., Starzinski‐Powitz, A., & Guo, S. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.06.008 · Cited by 79
Wagenfeld, A., Saunders, P. T. K., Whitaker, L., & Critchley, H. O. D. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1180368 · Cited by 79
Immunosuppressive effects of danazol in vitro
Hill, J. A., Barbieri, R. L., & Anderson, D. J. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59408-4 · Cited by 77
Whitaker, L. H. R., Murray, A. A., Matthews, R., Shaw, G., Williams, A. R. W., Saunders, P. T. K., & Critchley, H. O. D. (2017) · Human Reproduction · doi:10.1093/humrep/dew359 · Cited by 77 · cited 2×
“UPA inhibits human endometrial cell proliferation in vivo (Whitaker et al., 2017), and suppresses the growth”
BackgroundEvolution of medical treatment for endometriosis: back to the roots?
Wieser, F., Cohen, M., Gaeddert, A., Yu, J., Burks-Wicks, C., Berga, S. L., & Taylor, R. N. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm015 · Cited by 76
Altered retinoid uptake and action contributes to cell survival in endometriosis
Pavone, M. E., Reierstad, S., Sun, H., Milad, M., Bulun, S. E., & Cheng, Y.-H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0459 · Cited by 74
Kowalik, M. K., Rękawiecki, R., & Kotwica, J. (2013) · Reproductive Biology · doi:10.1016/j.repbio.2013.09.001 · Cited by 74
Igarashi, M., Iizuka, M., Abe, Y., & Ibuki, Y. (1998) · Human Reproduction · doi:10.1093/humrep/13.7.1952 · Cited by 73
Morotti, M., Remorgida, V., Venturini, P. L., & Ferrero, S. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.05.016 · Cited by 72
Localization in Tissues and Secretion of Eotaxin by Cells from Normal Endometrium and Endometriosis1
Hornung, D., Dohrn, K., Sotlar, K., Greb, R. R., Wallwiener, D., Kiesel, L., & Taylor, R. N. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6665 · Cited by 72
Leonardo-Pinto, J. P., Benetti-Pinto, C. L., Cursino, K., & Yela, D. A. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.02.015 · Cited by 72
Neumann, F. (1978) · PubMed · Cited by 72
Cobellis, L., Razzi, S., Fava, A., Severi, F. M., Igarashi, M., & Petraglia, F. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.11.058 · Cited by 71 · cited 2×
“Subsequent initiatives of danazol administration by vaginal or intrauterine routes resulted in much improved tolerance while keeping the therapeutic effects (Cobellis et al., 2004; Igarashi et al., 1998; Razzi et al., 2007a), but the drug never regained its former popularity.”
BackgroundSelf-citationPark, S. Y., Kim, S. H., Chae, H. D., Kim, C.-H., & Kang, B. M. (2016) · Clinical and Experimental Reproductive Medicine · doi:10.5653/cerm.2016.43.4.215 · Cited by 71
Effects of Progestin-Induced Pseudopregnancy on Endometriosis: Clinical and Microscopic Studies
Andrews, M. C., Andrews, W. C., & Strauss, A. F. (1959) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)36574-7 · Cited by 70
Ferrero, S., Remorgida, V., Venturini, P. L., & Maggiore, U. L. R. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.11.030 · Cited by 69
A comprehensive review of hormonal and biological therapies for endometriosis: latest developments
Barra, F., Grandi, G., Tantari, M., Scala, C., Facchinetti, F., & Ferrero, S. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1581761 · Cited by 69
Association of progesterone receptor polymorphism with recurrent abortions
Schweikert, A., Rau, T., Berkholz, A., Alléra, A., Daufeldt, S., & Wildt, L. (2004) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2003.04.002 · Cited by 69
Kommagani, R., Szwarc, M. M., Vasquez, Y. M., Peavey, M. C., Mazur, E. C., Gibbons, W. E., Lanz, R. B., DeMayo, F. J., & Lydon, J. P. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1005937 · Cited by 68
Eaton, J. L., Unno, K., Caraveo, M., Lu, Z., & Kim, J. J. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1661 · Cited by 67
Hormonal changes associated with Danazol therapy.
Wood, G. P., Wu, C. H., Flickinger, G. L., & Mikhail, G. (1975) · PubMed · Cited by 67
Koumantakis, E., Matalliotakis, I., Neonaki, M., Froudarakis, G., & Georgoulias, V. (1994) · Archives of Gynecology and Obstetrics · doi:10.1007/bf02390936 · Cited by 65 · cited 1×
“Moreover, danazol suppresses the production of IL-1β by human monocytes in vitro (Mori et al., 1990) and, coherently with this mechanism, danazol administration to women with endometriosis results in a decrease in serum IL-6 and IL-1α levels (Koumantakis et al., 1994).”
BackgroundBruner-Tran, K. L., Zhang, Z., Eisenberg, E., Winneker, R. C., & Osteen, K. G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2024 · Cited by 65
A stepped-care approach to symptomatic endometriosis management: A participatory research initiative
Vercellini, P., Donati, A., Ottolini, F., Frassineti, A., Fiorini, J., Nebuloni, V., Frattaruolo, M. P., Roberto, A., Mosconi, P., & Somigliana, E. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.01.037 · Cited by 64 · cited 3×
“Yet, knowing which hormonal treatment is more appropriate to treat each endometriosis phenotype would lead to a lesion-based therapeutic decision (Vercellini et al., 2018a) and possibly maximise patient adherence and treatment results.”
BackgroundMethodDanazol Suppresses the Production of Interleukin‐1β and Tumor Necrosis Factor by Human Monocytes
MORI, H., NAKAGAWA, M., ITOH, N., WADA, K., & TAMAYA, T. (1990) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1990.tb01037.x · Cited by 63
From pathogenesis to clinical practice: Emerging medical treatments for endometriosis
Clemenza, S., Sorbi, F., Noci, I., Capezzuoli, T., Turrini, I., Carriero, C., Buffi, N., Fambrini, M., & Petraglia, F. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.021 · Cited by 63
Self-citationCheng, Y.-H., Imir, A. G., Fenkçi, V., Yılmaz, M. B., & Bulun, S. E. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.12.014 · Cited by 62
Razzi, S., Luisi, S., Ferretti, C., Calonaci, F., Gabbanini, M., Mazzini, M., & Petraglia, F. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2006.08.002 · Cited by 62
Self-citationCULLEN, T. S. (1909) · The American Journal of the Medical Sciences · doi:10.1097/00000441-190901000-00019 · Cited by 62
Progesterone receptor modulators for endometriosis
Fu, J., Song, H., Zhou, M., Zhu, H., Wang, Y., Chen, H., & Huang, W. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009881.pub2 · Cited by 61
Keator, C. S., Mah, K., & Slayden, O. D. (2012) · Molecular Human Reproduction · doi:10.1093/molehr/gas006 · Cited by 60
A-Ring Reduced Metabolites of 19-nor Synthetic Progestins as Subtype Selective Agonists for ERα
Larrea, F., García-Becerra, R., Lemus, A. E., García, G. A., Pérez-Palacios, G., Jackson, K. J., Coleman, K. M., Dace, R., Smith, C. L., & Cooney, A. J. (2001) · Endocrinology · doi:10.1210/endo.142.9.8401 · Cited by 60
The immninent dawn of SPRMs in obstetrics and gynecology
Chabbert‐Buffet, N., Pintiaux, A., & Bouchard, P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.02.021 · Cited by 60
Giorgi, V. S. I., Broi, M. G. D., de Paz, C. C. P., Ferriani, R. A., & Navarro, P. A. (2016) · Reproductive Sciences · doi:10.1177/1933719115602772 · Cited by 59
Bentamapimod (JNK Inhibitor AS602801) Induces Regression of Endometriotic Lesions in Animal Models
Palmer, S. S., Altan, M., Denis, D., Tos, E. G., Gotteland, J., Osteen, K. G., Bruner‐Tran, K. L., & Nataraja, S. G. (2016) · Reproductive Sciences · doi:10.1177/1933719115600553 · Cited by 57
Ferrero, S., Leone Roberti Maggiore, U., Scala, C., Di Luca, M., Venturini, P. L., & Remorgida, V. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2581-2 · Cited by 57
Su, R.-W., Strug, M. R., Jeong, J.-W., Miele, L., & Fazleabas, A. T. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520441113 · Cited by 57
Zanatta, A., Pereira, R., da Rocha, A. M., Cogliati, B., Baracat, E. C., Taylor, H. S., Motta, E. L. A., & Serafini, P. C. (2015) · Reproductive Sciences · doi:10.1177/1933719114549846 · Cited by 56
ANDROGENIC, SYNANDROGENIC, AND ANTIANDROGENIC ACTIONS OF PROGESTINS*
Bullock, L. P., & Bardin, C. W. (1977) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1977.tb29427.x · Cited by 56
Grandi, G., Mueller, M., Bersinger, N., Papadia, A., Nirgianakis, K., Cagnacci, A., & McKinnon, B. (2016) · American Journal of Reproductive Immunology · doi:10.1111/aji.12552 · Cited by 55
Rocha, C. V., Da Broi, M. G., Miranda-Furtado, C. L., Navarro, P. A., Ferriani, R. A., & Meola, J. (2019) · Reproductive Sciences · doi:10.1177/1933719119828078 · Cited by 55
Gomes, M. K. O., Rosa-e-Silva, J. C., Garcia, S. B., de Sa Rosa-e-Silva, A. C. J., Turatti, A., Vieira, C. S., & Ferriani, R. A. (2009) · Human Reproduction · doi:10.1093/humrep/dep288 · Cited by 54 · cited 6×
“ptomatic women with endometriosis (Engemise et al., 2011; Gomes et al., 2009).”
BackgroundInfluentialLete, I., Mendoza, N., de la Viuda, E., & Carmona, F. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.07.002 · Cited by 54
Morelli, M., Sacchinelli, A., Venturella, R., Mocciaro, R., & Zullo, F. (2013) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/jog.12030 · Cited by 52
Amini, P., Michniuk, D., Kuo, K., Yi, L., Skomorovska-Prokvolit, Y., Peters, G. A., Tan, H., Wang, J., Malemud, C. J., & Mesiano, S. A. (2016) · Endocrinology · doi:10.1210/en.2016-1654 · Cited by 52
Cheewadhanaraks, S., Choksuchat, C., Dhanaworavibul, K., & Liabsuetrakul, T. (2012) · Gynecologic and Obstetric Investigation · doi:10.1159/000337713 · Cited by 51
Makabe, T., Koga, K., Miyashita‐Ishiwata, M., Takeuchi, A., Sue, F., Taguchi, A., Urata, Y., Izumi, G., Takamura, M., Harada, M., et al. (2016) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2016.12.002 · Cited by 51
The morphologic effect of short-term medical therapy of endometriosis
Brosens, I. A., Verleyen, A., & Cornillie, F. J. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(87)80297-1 · Cited by 50
Expression and regulation of estrogen-converting enzymes in ectopic human endometrial tissue
Fechner, S., Husen, B., Thole, H., Schmidt, M., Gashaw, I., Kimmig, R., Winterhager, E., & Grümmer, R. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.153 · Cited by 48
Mizutani, T., Nishiyama, S., Amakawa, I., Watanabe, A., Nakamuro, K., & Terada, N. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57594-3 · Cited by 48
Yu, J., Boicea, A., Barrett, K. L., James, C. O., Bagchi, I. C., Bagchi, M. K., Nezhat, C., Sidell, N., & Taylor, R. N. (2014) · MHR: Basic science of reproductive medicine · doi:10.1093/molehr/gat087 · Cited by 47
Progestin Therapy in Endometriosis
Gezer, A., & Oral, E. (2015) · Women's Health · doi:10.2217/whe.15.42 · Cited by 47
Endometrial changes during ulipristal acetate use: A systematic review
de Milliano, I., Hattum, D. V., Ket, J. C. F., Huirne, J. A. F., & Hehenkamp, W. J. K. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.04.042 · Cited by 47
Progesterone receptor profile in the decidua and fetal membrane
Goldman, S., & Shalev, E. (2006) · Frontiers in bioscience · doi:10.2741/2088 · Cited by 47
Vandenberg, G., DeVane, G. W., & Yen, S. S. C. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107727 · Cited by 46
Endometriosis: Science and Practice
(2011) · Wiley eBooks · doi:10.1002/9781444398519 · Cited by 45
de Carvalho, C. V., Nogueira-de-Souza, N. C., Massad Costa, A. M., Baracat, E. C., Girão, M. J. B. C., D'amora, P., Schor, E., & Da Silva, I. D. C. G. (2007) · Gynecological Endocrinology · doi:10.1080/09513590601024707 · Cited by 44
Endometriosis; etiologic role of marriage age and parity; conservative treatment.
Jv, M. (1953) · PubMed · Cited by 44
Tarjanne, S., Ng, C. H. M., Manconi, F., Arola, J., Mentula, M., Maneck, B., Fraser, I. S., & Heikinheimo, O. (2015) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12652 · Cited by 44
The migrating adenomyoma: past views on the etiology of adenomyosis and endometriosis
Hudelist, G., Keckstein, J., & Wright, J. T. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.086 · Cited by 42
Ichioka, M., Mita, S., Shimizu, Y., Imada, K., Kiyono, T., Bono, Y., & Kyo, S. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.12.008 · Cited by 42
Chen, Y., Wang, Y., Zhuang, Y., Zhou, F., & Huang, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036413 · Cited by 41
Liang, B., Wu, L., Xu, H., Cheung, C. W., Fung, W. Y., Wong, S. W., & Wang, C. C. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0347-9 · Cited by 41 · cited 4×
“and development of endometriotic implants in mice (Liang et al., 2018).”
BackgroundInfluentialB lymphocytes inactivation by Ibrutinib limits endometriosis progression in mice
Riccio, L. G. C., Jeljeli, M. M., Santulli, P., Chouzenoux, S., Doridot, L., Nicco, C., dos Reis, F. M., Abrão, M. S., Chapron, C., & Batteux, F. (2019) · Human Reproduction · doi:10.1093/humrep/dez071 · Cited by 41
Self-citationDienogest reduces HSD17β1 expression and activity in endometriosis
Mori, T., Ito, F., Matsushima, H., Takaoka, O., Koshiba, A., Tanaka, Y., Kusuki, I., & Kitawaki, J. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0052 · Cited by 40
Tsuno, A., Nasu, K., Yuge, A., Matsumoto, H., Nishida, M., & Narahara, H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0207 · Cited by 40
Human endometrial stromal cell decidualization requires transcriptional reprogramming by PLZF†
Szwarc, M. M., Hai, L., Gibbons, W. E., Peavey, M. C., White, L. D., Mo, Q., Lonard, D. M., Kommagani, R., Lanz, R. B., DeMayo, F. J., et al. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox161 · Cited by 40
D’Amora, P., Maciel, T. T., Tambellini, R., Mori, M. A., Pesquero, J. B., Sato, H., Girão, M. J. B. C., da Silva, I. D. C. G., & Schor, E. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080966 · Cited by 39
Taniguchi, F., Enatsu, A., Ota, I., Toda, T., Arata, K., & Harada, T. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.06.006 · Cited by 39
Efficacy and Safety of Long-Term Use of Dienogest in Women With Ovarian Endometrioma
Lee, S. R., Yi, K. W., Song, J. Y., Seo, S. K., Lee, D.-Y., Cho, S., & Kim, S. H. (2018) · Reproductive Sciences · doi:10.1177/1933719117725820 · Cited by 39
Vilaprisan in women with uterine fibroids: the randomized phase 2b ASTEROID 1 study
Bradley, L. D., Singh, S. S., Simon, J. A., Gemzell‐Danielsson, K., Petersdorf, K., Groettrup‐Wolfers, E., Ren, X., Zvolanek, M., & Seitz, C. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.10.012 · Cited by 39
Novembri, R., Borges, L. E., Carrarelli, P., Rocha, A. L. L., De Pascalis, F., Florio, P., & Petraglia, F. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2263 · Cited by 38
Self-citationMei, L., Bao, J., Tang, L., Zhang, C., Wang, H., Sun, L., Ma, G., Huang, L., Yang, J., Zhang, L., et al. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.01.012 · Cited by 36
Gonadotrophin-Releasing Hormone Analogues for Pain Associated With Endometriosis
(2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31820cb0fd · Cited by 36
Genetic Polymorphisms in Sex Hormone Metabolizing Genes and Drug Response in Women with Epilepsy
Grover, S., Talwar, P., Gourie‐Devi, M., Gupta, M., Bala, K., Sharma, S., Baghel, R., Kaur, H., Sharma, A., & Kukreti, R. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.120 · Cited by 36
The Role of a Mitochondrial Progesterone Receptor (PR-M) in Progesterone Action
Dai, Q., & Price, T. M. (2015) · Seminars in Reproductive Medicine · doi:10.1055/s-0035-1552583 · Cited by 36
Engemise, S. L., Willets, J. M., Taylor, A. H., Emembolu, J. O., & Konje, J. C. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.02.013 · Cited by 35
Aoyagi, Y., Nasu, K., Kai, K., Hirakawa, T., Okamoto, M., Kawano, Y., Abe, W., Tsukamoto, Y., Moriyama, M., & Narahara, H. (2016) · Reproductive Sciences · doi:10.1177/1933719116657894 · Cited by 34
Stoeckemann, K., Hegele-Hartung, C., & Chwalisz, K. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a135900 · Cited by 33
CYP17 and CYP2C19 gene polymorphisms in patients with endometriosis
Bozdağ, G., Alp, A., Sarıbaş, Z., Tuncer, S., Aksu, T., & Gürgan, T. (2009) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2009.11.007 · Cited by 32
Dienogest mediates midkine suppression in endometriosis
Nirgianakis, K., Grandi, G., McKinnon, B., Bersinger, N., Cagnacci, A., & Mueller, M. (2016) · Human Reproduction · doi:10.1093/humrep/dew180 · Cited by 31
Effect of mifepristone in the different treatments of endometriosis
Zhang, Y. X. (2016) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog2086.2016 · Cited by 30
Couzinet, B., Young, J., Brailly, S., Chanson, P., Thomas, J. L., & SCHAISON, G. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954018 · Cited by 30
Selective progesterone receptor modulators: an update
Benagiano, G., Bastianelli, C., Farris, M., & Brosens, I. A. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.914494 · Cited by 30
Antiproliferative and apoptotic effects of norethisterone on endometriotic stromal cells in vitro
Minami, T., Kosugi, K., Suganuma, I., Yamanaka, K., Kusuki, I., Oyama, T., & Kitawaki, J. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2012.08.023 · Cited by 29
Schultze‐Mosgau, M., Höchel, J., Prien, O., Zimmermann, T., Brooks, A., Bush, J. A., & Rottmann, A. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0607-4 · Cited by 29
Patel, B., Peters, G. A., Skomorovska-Prokvolit, Y., Yi, L., Tan, H., Yousef, A., Wang, J., & Mesiano, S. A. (2018) · Reproductive Sciences · doi:10.1177/1933719117716775 · Cited by 29
Genetic polymorphisms influence the steroid treatment of children with idiopathic nephrotic syndrome
Chiou, Y., Wang, L., Wang, T.-H., & Huang, S.-P. (2012) · Pediatric Nephrology · doi:10.1007/s00467-012-2182-0 · Cited by 27
Braun, D. P., Gebel, H. M., & Dmowski, W. P. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56821-6 · Cited by 27
Binder, M., Zhang, B., Hillman, D. W., Kohli, R., Kohli, T., Lee, A., & Kohli, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071097 · Cited by 25
Sultana, S., Kajihara, T., Mizuno, Y., Sato, T., Oguro, T., Kimura, M., Akita, M., & Ishihara, O. (2017) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12028 · Cited by 25
Interventions for managing root caries
Tan, H., Richards, L., Walsh, T., Worthington, H. V., Clarkson, J., Wang, L., & Velo, M. M. D. A. C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012750 · Cited by 25
Continuous Amenorrhea May Be Insufficient to Stop the Progression of Colorectal Endometriosis
Millochau, J.-C., Abo, C., Darwish, B., Huet, E., Dietrich, G., & Roman, H. (2016) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2016.04.008 · Cited by 24 · cited 1×
“that in some cases it keeps growing and invading the organ wall despite continuous medication (Millochau et al., 2016).”
BackgroundHuman endometrium transplanted into nude mice. Histologic effects of various steroid hormones.
Bergqvist, A., Jeppsson, S., Kullander, S., & Ljungberg, O. (1985) · PubMed Central · Cited by 24
Progesterone receptor (PROGINS) polymorphism and the risk of endometrial cancer development
Junqueira, M. G., Silva, I. D. C. G. D., Nogueira-de-Souza, N. C., de Carvalho, C. V., Jabes, D. L., Gomes, M. T. V., Baracat, E. C., Lopes, L. A. F., Nicolau, S. M., & Gonçalves, W. J. (2006) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2006.00767.x · Cited by 24
Kannan, A., Bhurke, A., Sitruk-Ware, R. L., Lalitkumar, P. G., Gemzell‐Danielsson, K., Williams, A. R. W., Taylor, R. N., Bagchi, M. K., & Bagchi, I. C. (2017) · Reproductive Sciences · doi:10.1177/1933719117746764 · Cited by 23
Aberrant PTEN expression in response to progesterone reduces endometriotic stromal cell apoptosis
Choi, J., Jo, M., Lee, E., Hwang, S., & Choi, D. (2017) · Reproduction · doi:10.1530/rep-16-0322 · Cited by 23
Scala, C., Maggiore, U. L. R., Barra, F., Venturini, P. L., & Ferrero, S. (2018) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.01.022 · Cited by 21
Moreno, I., Quiñones, L. A., Catalan, J., Miranda, C., Roco, Á., Jaime Sasso, A., Tamayo, E., Cáceres, D., Tchernitchin, A. N., Gaete, L., et al. (2012) · Biomédica · doi:10.7705/biomedica.v32i4.789 · Cited by 21
Brichant, G., Nervo, P., Albert, A., Munaut, C., Foidart, J., & Nisolle, M. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1433160 · Cited by 21
YAMANAKA, T., Hirata, S., Shoda, T., & Hoshi, K. (2002) · Endocrine Journal · doi:10.1507/endocrj.49.473 · Cited by 20
EVALUATION OF DANAZOL AS AN ORAL CONTRACEPTIVE
Nh, L., & Wilson, K. H. (1977) · Inpharma Weekly · doi:10.1007/bf03289420 · Cited by 20
Medical Therapies for Endometriosis Differentially Inhibit Stem Cell Recruitment
Ersoy, G. Ş., Zolbin, M. M., Çoşar, E., Mamillapalli, R., & Taylor, H. S. (2017) · Reproductive Sciences · doi:10.1177/1933719116682879 · Cited by 20
Fenretinide:A Potential Treatment for Endometriosis
Pavone, M. E., Malpani, S. S., Dyson, M. T., Kim, J. J., & Bulun, S. E. (2016) · Reproductive Sciences · doi:10.1177/1933719116632920 · Cited by 19
Jang, G. R., & Benet, L. Z. (1997) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1023/a:1025725716343 · Cited by 18
Mabrouk, M., Paradisi, R., Arena, A., Del Forno, S., Matteucci, C., Zannoni, L., Caprara, G., & Seracchioli, R. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1405932 · Cited by 17
Dienogest inhibits C-C motif chemokine ligand 20 expression in human endometriotic epithelial cells
Mita, S., Nakakuki, M., Ichioka, M., Shimizu, Y., Hashiba, M., Miyazaki, H., & Kyo, S. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.04.048 · Cited by 17
Histology and ultrastructure of human endometriotic tissues treated with dydrogesterone (Duphaston)
Cornillie, F. J., Puttemans, P., & Brosens, I. A. (1987) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(87)90008-6 · Cited by 16
Vercellini, P., Ottolini, F. L., Frattaruolo, M. P., Buggio, L., Roberto, A., & Somigliana, E. (2018) · Reproductive Sciences · doi:10.1177/1933719117749759 · Cited by 16
Concurrent estrogen action was essential for maximal progestin effect in oral contraceptives
Bono, Y., Kyo, S., Kiyono, T., Mizumoto, Y., Nakamura, M., Maida, Y., Takakura, M., & Fujiwara, H. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.005 · Cited by 16
Robyn, C., Sch�ndorf, H., J�rgensen, O., DERICKS-TAN, J. S. E., & Taubert, H. ‐. (1973) · Archives of Gynecology and Obstetrics · doi:10.1007/bf00672676 · Cited by 15
Rozenberg, S., Praet, J., Pazzaglia, E., Gilles, C., Manigart, Y., & Vandromme, J. (2017) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12641 · Cited by 14
Development of a subcutaneous endometriosis rat model
Pereira, F. E. X. G., de Almeida, P. R. C., Dias, B. H. M., de Vasconcelos, P. R. L., Guimarães, S. B., & Medeiros, F. D. C. (2015) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-86502015001000002 · Cited by 14
Beranič, N., & Rižner, T. L. (2012) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.07.004 · Cited by 14
Chen, C.-C., Montalbano, A. P., Hussain, I., Lee, W.-R., & Mendelson, C. R. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.791350 · Cited by 14
Histomorphological changes in endometriosis in a patient treated with ulipristal: A case report
Bateman, J., Bougie, O., Singh, S. S., & Islam, S. (2016) · Pathology - Research and Practice · doi:10.1016/j.prp.2016.10.010 · Cited by 13
Taniguchi, F., Enatsu, A., Ikebuchi, A., Yamane, E., Moriyama, M., Murakami, J., Harada, T., & Harada, T. (2017) · Yonago acta medica · doi:10.33160/yam.2017.09.008 · Cited by 13
Jondet, M., Vacher‐Lavenu, M., & Chapron, C. (2006) · Angiogenesis · doi:10.1007/s10456-006-9044-y · Cited by 12
Self-citationPredictive Biomarkers May allow Precision Therapy of Endometriosis
Hou, Z., Mamillapalli, R., & Taylor, H. S. (2017) · Journal of Endometriosis and Pelvic Pain Disorders · doi:10.5301/jeppd.5000311 · Cited by 12
Couzinet, B. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.12.4218 · Cited by 12
Danazol Suppresses Both Spontaneous and Activated Human Lymphocyte‐Mediated Cytotoxicity
Viganò, P., Blasio, A. M. D., Busacca, M., Sabbadini, M. G., & Vignali, M. (1992) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1992.tb00754.x · Cited by 10
Research works printed but not linked: 4
- Andrews, 1976, Hormone therapy of endometriosis - estrogen, androgens, progestin estrogens, Excerpta Med, 368, 46
- Gerdes, 1998, Cloning and tissue expression of two putative steroid membrane receptors, Biol Chem, 379, 907
- Iskhakova, 2006, Polymorphism of the arylamine-n-acetyltransferase gene in endometriosis patients in the Republic of Bashkortostan, Balk J Med Genet, 9, 55
- Rokitansky, 1860, Über Uterusdrüsen-Neubildungen in Uterus- und Ovarial-Sarcomen, Zeitschrift der Kaiserlich Koenigl Gesellschaft der Aerzte zu Wien, 37, 577
Cited by
Endometriosis: Etiology, pathobiology, and therapeutic prospects
Saunders, P. T. K., & Horne, A. W. (2021) · Cell · doi:10.1016/j.cell.2021.04.041 · Cited by 961
Hormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
“The pathophysiology of endometriosis is still a matter of investigation, but endocrine and inflammatory backgrounds are well characterized, recognizing an estrogen-dependency [4] and a progesterone-resistance [5].”
BackgroundSelf-citationDonnez, J., & Dolmans, M.-M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051085 · Cited by 182
Progesterone Actions and Resistance in Gynecological Disorders
MacLean, J. A., & Hayashi, K. (2022) · Cells · doi:10.3390/cells11040647 · Cited by 176
“While PRA and PRB isoforms are detected in human eutopic endometrium with endometriosis during the menstrual cycle, both the expression of PRA and PRB are generally lower in any type of ectopic lesions [56].”
BackgroundProgesterone Resistance in Endometriosis: Current Evidence and Putative Mechanisms
Zhang, P., & Wang, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086992 · Cited by 162
Metadata
- Authors
- Reis, F. M., Coutinho, L. M., Vannuccini, S., Batteux, F., Chapron, C., & Petraglia, F.
- Affiliations
- Universidade Federal de Minas Gerais (BR)
- University of Siena (IT)
- Inserm (FR)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Corresponding author
- Petraglia, Felice
- ORCID
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-16
- Volume
- 26
- Issue
- 4
- Pages
- 565-585
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- PMC
- PMC7317284
- OpenAlex
- W3026807961
- Cited by
- 166
- References
- 210
- Citations by year
- 2026: 30 · 2025: 23 · 2024: 29 · 2023: 26 · 2022: 27 · 2021: 30 · 2020: 1
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Human Reproduction Update (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (201876/2017-5)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- endometriosis, progesterone receptor, progestins, selective progesterone receptor modulators, drug resistance, progesterone receptor isoforms, epigenetic regulation, oxidative stress, FOXO1, matrix metalloproteinases, connexin 43, aromatase, estradiol metabolism, deep infiltrating endometriosis, endometriosis phenotypes, hormone therapy
- MeSH terms
- Endometriosis, Endometrium, Female, Fertility Agents, Female, Humans, Ligands, Peritoneal Diseases, Progestins, Progesterone, Receptors, Progesterone, Uterine Diseases, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.